• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过“试管”模型和“充分搅拌”模型评估血浆蛋白结合动力学对肝脏清除率的影响。

Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.

作者信息

Jansen J A

出版信息

J Pharmacokinet Biopharm. 1981 Feb;9(1):15-26. doi: 10.1007/BF01059340.

DOI:10.1007/BF01059340
PMID:7229915
Abstract

The potential influence of protein binding kinetics on elimination from liver sinusoids was evaluated by means of a "well-stirred" model (I) and a "tube" model (II). When the dissociation rate constant (k-1) is at the estimated maximum, equilibrium is maintained during the passage of drug through the eliminating organ, and hence dissociation as such has no limiting effect on elimination. When, however, k-1 is at the estimated minimum, equilibrium is not maintained, the unbound fraction is reduced during the passage, and a significant decrease in the extraction ratio occurs when the unbound fraction is 0.01 or less. The models were furthermore used to investigate the effect of saturation, of both the binding protein and the elimination process, on elimination.

摘要

通过“充分搅拌”模型(I)和“管道”模型(II)评估了蛋白质结合动力学对从肝血窦消除的潜在影响。当解离速率常数(k-1)处于估计的最大值时,药物在通过消除器官的过程中保持平衡,因此解离本身对消除没有限制作用。然而,当k-1处于估计的最小值时,平衡无法维持,在通过过程中未结合分数降低,当未结合分数为0.01或更低时,提取率会显著下降。此外,这些模型还用于研究结合蛋白和消除过程的饱和对消除的影响。

相似文献

1
Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.通过“试管”模型和“充分搅拌”模型评估血浆蛋白结合动力学对肝脏清除率的影响。
J Pharmacokinet Biopharm. 1981 Feb;9(1):15-26. doi: 10.1007/BF01059340.
2
Hepatic elimination of drugs with concentration-dependent serum protein binding.肝脏对具有浓度依赖性血清蛋白结合的药物的消除作用。
J Pharmacokinet Biopharm. 1984 Feb;12(1):67-81. doi: 10.1007/BF01063611.
3
Determination of hepatic clearance with the account of drug-protein binding kinetics.测定肝清除率时需考虑药物蛋白结合动力学。
J Pharm Sci. 2012 Oct;101(10):3936-45. doi: 10.1002/jps.23235. Epub 2012 Jul 5.
4
Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.直接测定血浆中游离分数与微粒体系统中游离分数的比值(fu p/fu mic),以精确预测I相介导的肝脏代谢清除率。
J Pharmacol Toxicol Methods. 2011 Jan-Feb;63(1):35-9. doi: 10.1016/j.vascn.2010.04.003. Epub 2010 Apr 28.
5
Introducing the Dynamic Well-Stirred Model for Predicting Hepatic Clearance and Extraction Ratio.介绍用于预测肝脏清除率和提取率的动态搅拌模型。
J Pharm Sci. 2024 Apr;113(4):1094-1112. doi: 10.1016/j.xphs.2023.12.020. Epub 2024 Jan 12.
6
Commentary: a physiological approach to hepatic drug clearance.述评:肝脏药物清除的生理学方法
Clin Pharmacol Ther. 1975 Oct;18(4):377-90. doi: 10.1002/cpt1975184377.
7
Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation.蛋白结合和肝清除率:再探讨在离体灌流大鼠肝脏模型中,用地西泮评价肝清除率模型的区分度。
Drug Metab Dispos. 2019 Dec;47(12):1397-1402. doi: 10.1124/dmd.119.088872. Epub 2019 Sep 28.
8
Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.药物与蛋白质的共价和非共价结合:对肝脏清除、储存及细胞特异性药物递送的影响
Pharm Res. 1989 Feb;6(2):105-18. doi: 10.1023/a:1015961424122.
9
Variation in hepatic extraction ratio with unbound drug fraction: discrimination between models of hepatic drug elimination.
J Pharm Sci. 1985 Feb;74(2):205-7. doi: 10.1002/jps.2600740221.
10
Impact of input parameters on the prediction of hepatic plasma clearance using the well-stirred model.应用搅拌池模型预测肝血浆清除率中输入参数的影响。
Curr Drug Metab. 2010 Sep;11(7):583-94. doi: 10.2174/138920010792927334.

引用本文的文献

1
Re-discover the value of protein binding assessments in hepatic and renal impairment studies and its contributions in drug labels and dose decisions.重新发现蛋白结合评估在肝肾功能损害研究中的价值及其在药品标签和剂量决策中的贡献。
Clin Transl Sci. 2024 May;17(5):e13810. doi: 10.1111/cts.13810.
2
A rapid spectrofluorimetric technique for determining drug-serum protein binding suitable for high-throughput screening.一种适用于高通量筛选的测定药物与血清蛋白结合的快速荧光光谱技术。
Pharm Res. 2000 May;17(5):632-7. doi: 10.1023/a:1007537520620.
3
Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal.

本文引用的文献

1
Effect of plasma protein and tissue binding on the time course of drug concentration in plasma.血浆蛋白和组织结合对血浆中药物浓度时程的影响。
J Pharmacokinet Biopharm. 1979 Apr;7(2):195-206. doi: 10.1007/BF01059738.
2
Estimation of hepatic blood flow with indocyanine green.用吲哚菁绿评估肝血流量。
J Clin Invest. 1962 May;41(5):1169-79. doi: 10.1172/JCI104570.
3
[Hemodynamics of kidney medullary substance. Part I. Capillary passage time, blood volume, circulation, tissue hematocrit and oxygen consumption of kidney medullary substance in situ].
非线性蛋白质结合与酶的异质性:对肝脏药物清除的影响。
J Pharmacokinet Biopharm. 1993 Feb;21(1):43-74. doi: 10.1007/BF01061775.
4
Changes in renal clearance of furosemide due to changes in renal blood flow and plasma albumin concentration.由于肾血流量和血浆白蛋白浓度的变化而导致的呋塞米肾清除率的变化。
Eur J Clin Pharmacol. 1993;45(2):135-9. doi: 10.1007/BF00315494.
5
Hepatic elimination of drugs with concentration-dependent serum protein binding.肝脏对具有浓度依赖性血清蛋白结合的药物的消除作用。
J Pharmacokinet Biopharm. 1984 Feb;12(1):67-81. doi: 10.1007/BF01063611.
6
Protein binding and drug clearance.蛋白质结合与药物清除率。
Clin Pharmacokinet. 1984 Jan;9 Suppl 1:10-7. doi: 10.2165/00003088-198400091-00002.
7
Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.蛋白结合与肝脏清除率:在离体灌注大鼠肝脏制备中,用高内在清除率药物地西泮区分肝脏清除率模型。
J Pharmacokinet Biopharm. 1984 Apr;12(2):129-47. doi: 10.1007/BF01059274.
8
Theoretical consideration of drug distribution kinetics in a noneliminating organ: comparison between a "homogeneous (well-stirred)" model and "nonhomogeneous (tube)" model.
J Pharmacokinet Biopharm. 1985 Jun;13(3):265-87. doi: 10.1007/BF01065656.
9
Dissociation from albumin: a potentially rate-limiting step in the clearance of substances by the liver.与白蛋白解离:肝脏清除物质过程中一个潜在的限速步骤。
Proc Natl Acad Sci U S A. 1985 Mar;82(5):1563-7. doi: 10.1073/pnas.82.5.1563.
10
Competition between two enzymes for substrate removal in liver: modulating effects due to substrate recruitment of hepatocyte activity.肝脏中两种酶对底物清除的竞争:肝细胞活性底物募集的调节作用。
J Pharmacokinet Biopharm. 1987 Oct;15(5):473-96. doi: 10.1007/BF01061758.
[肾髓质物质的血流动力学。第一部分。原位肾髓质物质的毛细血管通过时间、血容量、循环、组织血细胞比容和氧消耗]
Pflugers Arch Gesamte Physiol Menschen Tiere. 1960;270:251-69.
4
A linear method for determining liver sinusoidal and extravascular volumes.一种用于确定肝窦和血管外容积的线性方法。
Am J Physiol. 1963 Apr;204:626-40. doi: 10.1152/ajplegacy.1963.204.4.626.
5
Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction.吲哚菁绿:关于其物理性质、血浆衰变及肝脏摄取的观察
J Clin Invest. 1960 Apr;39(4):592-600. doi: 10.1172/JCI104072.
6
The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.吲哚菁绿在肝血流测量及肝功能检测中的应用。
Clin Sci. 1961 Aug;21:43-57.
7
Binding of sulfobromophthalein (BSP) sodium and indocyanine green (ICG) by plasma alpha-1 lipoproteins.血浆α-1脂蛋白对磺溴酞钠(BSP)和吲哚菁绿(ICG)的结合作用。
Proc Soc Exp Biol Med. 1966 Aug-Sep;122(4):957-63. doi: 10.3181/00379727-122-31299.
8
Kinetics of elimination of drugs possessing high affinity for the plasma proteins.对血浆蛋白具有高亲和力的药物的消除动力学。
Nature. 1965 Aug 28;207(5000):959-60. doi: 10.1038/207959a0.
9
Pharmacokinetic models regarding protein binding of drugs.关于药物蛋白结合的药代动力学模型。
Antimicrob Agents Chemother (Bethesda). 1965;5:183-91.
10
Equilibrium and kinetic properties of the Evans blue-albumin system.伊文思蓝-白蛋白系统的平衡和动力学性质
Am J Physiol. 1969 Mar;216(3):675-81. doi: 10.1152/ajplegacy.1969.216.3.675.